Comparative Effects of Mulligan Pain Release Phenomenon With and Without Tapping in Patellofemoral Pain Syndrome

NCT06108804 | Unknown

• 1 other identifier: REC/RCR&AHS/23/0142
• Study Type: interventional
• Target: 32
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to compare the effects of mulligan pain release phenomenon with or without Tapping in management of Patellofemoral pain syndrome

Conditions

Patellofemoral Pain Syndrome

Keywords

patellofemoral pain syndrome; mulligan's pain release phenomenon; tapping; kujala scale

Outcome Measures

Primary Outcomes (4)

• Numeric Pain Rating Scale

  Changes from baseline. The NPRS is a self-reporting or clinician-administered measuring tool that has extreme values ranging from "no pain" to "severe pain", on either horizontal or vertical line of scale.NPRS which is an eleven point scale in which no pain (score 0) and highest pain (score 10)

  4th week

• Knee Flexion Range of Motion

  Changes from baseline. The measurement of joint range of motion (ROM) is an essential procedure used in physical therapy, known as goniometry

  4th week

• Knee Extension Range of Motion

  Changes from baseline. The measurement of joint range of motion (ROM) is an essential procedure used in physical therapy, known as goniometry

  4th week

• Kujala Score (AKPS)

  Changes from baseline. Kujala score is a 13 items, self-report questionnaire for the patients having Patellofemoral pain syndrome (PFPS). Kujala has been demonstrated to be valid and reliable in PFPS patients and can be utilized for clinical evaluation as well as research work.

  4th week

Study Arms (2)

mulligan pain release phenomenon with tapping.

EXPERIMENTAL

Participants in group A will receive mulligan pain release phenomenon with tapping.

Other: mulligan pain release phenomenon with tapping

mulligan pain release phenomenon

ACTIVE COMPARATOR

Participants in group B will receive mulligan pain release phenomenon

Other: mulligan pain release phenomenon

Interventions

mulligan pain release phenomenon with tapping OTHER

Participants in Group A will receive mulligan pain release phenomenon with tapping.First, demographic information will be gathered, pain severity will be measured using NPRS, knee joint range of motion (flexion/extension) will be measured using a goniometer, and functional limitation will be evaluated using a Kujala score.Two sessions of treatment per week with a total of eight session will be given in four weeks

Also known as: tapping

mulligan pain release phenomenon with tapping.

mulligan pain release phenomenon OTHER

Two sessions of treatment per week with a total of eight session will be given in four weeks.Group B will receive mulligan pain release phenomenon only. First, demographic information will be gathered, pain severity will be measured using NPRS. knee joint range of motion (flexion/extension) will be measured using a goniometer, and functional limitation will be evaluated using a Kujala score.

mulligan pain release phenomenon

Eligibility Criteria

• Age: 20 Years - 40 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Age 20 to 40 years
• Both male and female
• NPRS\>3
• AKPS ≥6
• ROM\<135 ° rarely. Knee range of motion is usually normal in patients of Patellofemoral pain syndrome.
• Positive patellar grind test
• Adults having anterior knee pain from previous duration of 2-3 months which is aggravated by walking, stairs ambulation or prolong sitting.

You may not qualify if:

• Recent fracture/trauma
• Acute diseased condition
• Knee surgery
• Tumor or infection around the knee
• Rheumatoid Arthritis
• Pregnancy
• Any malformation or joint hypermobility
• patellar tendon pathology

Sponsors & Collaborators

• Riphah International University: lead

Study Sites (1)

Kot Khawaja Saeed Hospital

Lahore, Punjab Province, 54600, Pakistan

RECRUITING

Related Publications (7)

• Chang WD, Chen FC, Lee CL, Lin HY, Lai PT. Effects of Kinesio Taping versus McConnell Taping for Patellofemoral Pain Syndrome: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2015;2015:471208. doi: 10.1155/2015/471208. Epub 2015 Jun 21.

  PMID: 26185517 BACKGROUND

• Baldon Rde M, Nakagawa TH, Muniz TB, Amorim CF, Maciel CD, Serrao FV. Eccentric hip muscle function in females with and without patellofemoral pain syndrome. J Athl Train. 2009 Sep-Oct;44(5):490-6. doi: 10.4085/1062-6050-44.5.490.

  PMID: 19771287 BACKGROUND

• Taunton JE, Ryan MB, Clement DB, McKenzie DC, Lloyd-Smith DR, Zumbo BD. A retrospective case-control analysis of 2002 running injuries. Br J Sports Med. 2002 Apr;36(2):95-101. doi: 10.1136/bjsm.36.2.95.

  PMID: 11916889 BACKGROUND

• Pal S, Draper CE, Fredericson M, Gold GE, Delp SL, Beaupre GS, Besier TF. Patellar maltracking correlates with vastus medialis activation delay in patellofemoral pain patients. Am J Sports Med. 2011 Mar;39(3):590-8. doi: 10.1177/0363546510384233. Epub 2010 Nov 12.

  PMID: 21076015 BACKGROUND

• Leibbrandt DC, Louw QA. The use of McConnell taping to correct abnormal biomechanics and muscle activation patterns in subjects with anterior knee pain: a systematic review. J Phys Ther Sci. 2015 Jul;27(7):2395-404. doi: 10.1589/jpts.27.2395. Epub 2015 Jul 22.

  PMID: 26311990 BACKGROUND

• Logan CA, Bhashyam AR, Tisosky AJ, Haber DB, Jorgensen A, Roy A, Provencher MT. Systematic Review of the Effect of Taping Techniques on Patellofemoral Pain Syndrome. Sports Health. 2017 Sep/Oct;9(5):456-461. doi: 10.1177/1941738117710938. Epub 2017 Jun 15.

  PMID: 28617653 BACKGROUND

• Arrebola LS, Teixeira de Carvalho R, Lam Wun PY, Rizzi de Oliveira P, Firmo Dos Santos J, Coutinho de Oliveira VG, Pinfildi CE. Investigation of different application techniques for Kinesio Taping(R) with an accompanying exercise protocol for improvement of pain and functionality in patients with patellofemoral pain syndrome: A pilot study. J Bodyw Mov Ther. 2020 Jan;24(1):47-55. doi: 10.1016/j.jbmt.2019.05.022. Epub 2019 May 22.

  PMID: 31987562 BACKGROUND

MeSH Terms

Conditions

Patellofemoral Pain Syndrome

Condition Hierarchy (Ancestors)

Joint Diseases; Musculoskeletal Diseases

Study Officials

• Humera Mubashar, MS

  Riphah International University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Imran Amjad, Phd

CONTACT

03324390125; imran.amjad@riphah.edu.pk

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Masking Details: single blinded
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: A parallel study is a type of clinical study in which two or more groups of participants receive different interventions.

Study Record Dates

• First Submitted: October 25, 2023
• First Posted: October 31, 2023
• Study Start: October 20, 2023
• Primary Completion: December 1, 2023
• Study Completion: January 1, 2024
• Last Updated: October 31, 2023

Record last verified: 2023-10

Data Sharing

• IPD Sharing: Will not share

Locations

PA (1)